Loading clinical trials...
Loading clinical trials...
Optimal Timing of Intravesical GAG Restoration Therapy for BCG-Induced Bladder Toxicity in Patients With Non-Muscle-Invasive Bladder Cancer: A Prospective Randomized Study
Conditions
Interventions
Hyaluronic Acid and Chondroitin Sulfate (Blad-Care™)
Locations
1
South Korea
Kyung Hee University Hospital
Seoul, Dongdaemun-gu, South Korea
Start Date
November 3, 2025
Primary Completion Date
December 1, 2026
Completion Date
June 1, 2027
Last Updated
March 27, 2026
NCT04389632
NCT07222488
NCT05614739
NCT06441110
NCT06403202
NCT03459846
Lead Sponsor
BLAD-HYA Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions